Published in Hepatitis Weekly, December 12th, 2005
Interim study results from the Retreatment with Pegasys in Patients Not Responding to Peg-Intron Therapy (REPEAT) study was presented at the 56th annual meeting of the American Association for the Study of Liver Diseases (AASLD).
The U.S. National Institutes of Health Consensus Development Conference Statement on the Management of Hepatitis C...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly